← Eichor
Condition: Asplenia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Asplenia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Development of an Italian Questionnaire for Splenectomized Patients Using a Delphi Consensus Method
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07428005Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
Phase 2 · 1 location(s) · University of California, Davis · NCT02232191Molecular Genetics of Heterotaxy and Related Congenital Heart Defects
Phase N/A · 1 location(s) · Indiana University · NCT02432079Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Evaluation of the Effectiveness of an Educational Intervention in Splenectomized Patients
Phase N/A · 2 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07354893Meningococcal B Vaccine in Patients with Asplenia
Phase 2 · 1 location(s) · Medical University of Vienna · NCT06025487Assessment of Complication Risk Factors in a French National Cohort of Asplenic Patients
Phase N/A · 12 location(s) · Poitiers University Hospital · NCT04199403Research Trial Assessing the Immunogenicity and Safety of Three Meningococcal B Vaccine Strategies Among Patients With A
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04166656
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.